Clover Health Investments Corp. (CLOV)

$0.6222

-0.01

(-2.11%)▲

Market is closed - opens 7 PM, 23 Apr 2024

Performance

  • $0.61
    $0.65
    $0.62
    downward going graph

    2.26%

    Downside

    Day's Volatility :6.63%

    Upside

    4.47%

    downward going graph
  • $0.61
    $1.63
    $0.62
    downward going graph

    2.26%

    Downside

    52 Weeks Volatility :62.82%

    Upside

    61.96%

    downward going graph

Returns

PeriodClover Health Investments Corp.
3 Months
-36.25%
6 Months
-31.15%
1 Year
-17.47%
3 Years
-91.78%

Highlights

Market Capitalization
314.8M
Book Value
$0.59
Earnings Per Share (EPS)
-0.44
Wall Street Target Price
1.44
Profit Margin
-10.48%
Operating Margin TTM
-10.35%
Return On Assets TTM
-16.98%
Return On Equity TTM
-66.34%
Revenue TTM
2.0B
Revenue Per Share TTM
4.22
Quarterly Revenue Growth YOY
-44.3%
Gross Profit TTM
126.2M
EBITDA
-186.1M
Diluted Eps TTM
-0.44
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-0.22
EPS Estimate Next Year
-0.2
EPS Estimate Current Quarter
-0.14
EPS Estimate Next Quarter
-0.07

Analyst Recommendation

Buy
    60%Buy
    40%Hold
    0
    0%Sell
Based on 10 Wall street analysts offering stock ratings for Clover Health Investments Corp.(by analysts ranked 0 to 5 stars)
Based on 10 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
1
1
Hold
4
5
5
Sell
00
4
5

Analyst Forecast

What analysts predicted

Upside of 131.44%

Current $0.62
Target $1.44

Company Financials

FY19Y/Y Change
Revenue
462.3M
-
Net Income
-402.8M
-
Net Profit Margin
-87.14%
-
FY20Y/Y Change
Revenue
672.9M
↑ 45.56%
Net Income
-148.7M
↓ 63.09%
Net Profit Margin
-22.1%
↑ 65.04%
FY21Y/Y Change
Revenue
1.5B
↑ 118.76%
Net Income
-604.7M
↑ 306.66%
Net Profit Margin
-41.08%
↓ 18.98%
FY22Y/Y Change
Revenue
3.5B
↑ 136.19%
Net Income
-305.4M
↓ 49.49%
Net Profit Margin
-8.78%
↑ 32.3%
FY23Y/Y Change
Revenue
2.0B
↓ 41.64%
Net Income
-213.4M
↓ 30.14%
Net Profit Margin
-10.52%
↓ 1.74%
Q3 FY22Q/Q Change
Revenue
856.8M
↑ 1.19%
Net Income
-76.3M
↓ 27.63%
Net Profit Margin
-8.9%
↑ 3.55%
Q4 FY22Q/Q Change
Revenue
898.8M
↑ 4.9%
Net Income
-61.6M
↓ 19.21%
Net Profit Margin
-6.86%
↑ 2.04%
Q1 FY23Q/Q Change
Revenue
527.8M
↓ 41.28%
Net Income
-72.6M
↑ 17.81%
Net Profit Margin
-13.76%
↓ 6.9%
Q2 FY23Q/Q Change
Revenue
513.6M
↓ 2.68%
Net Income
-28.8M
↓ 60.31%
Net Profit Margin
-5.61%
↑ 8.15%
Q3 FY23Q/Q Change
Revenue
482.1M
↓ 6.14%
Net Income
-41.5M
↑ 43.92%
Net Profit Margin
-8.6%
↓ 2.99%
Q4 FY23Q/Q Change
Revenue
505.4M
↑ 4.85%
Net Income
-70.5M
↑ 69.94%
Net Profit Margin
-13.94%
↓ 5.34%
FY19Y/Y Change
Total Assets
100.3K
-
Total Liabilities
118.0K
-
FY20Y/Y Change
Total Assets
267.3M
↑ 266230.5%
Total Liabilities
835.6M
↑ 708203.31%
FY21Y/Y Change
Total Assets
950.8M
↑ 255.77%
Total Liabilities
411.5M
↓ 50.76%
FY22Y/Y Change
Total Assets
808.6M
↓ 14.95%
Total Liabilities
460.9M
↑ 12.0%
FY23Y/Y Change
Total Assets
570.7M
↓ 29.43%
Total Liabilities
284.3M
↓ 38.32%
Q3 FY22Q/Q Change
Total Assets
1.6B
↓ 24.5%
Total Liabilities
1.2B
↓ 28.76%
Q4 FY22Q/Q Change
Total Assets
808.6M
↓ 48.09%
Total Liabilities
460.9M
↓ 60.46%
Q1 FY23Q/Q Change
Total Assets
1.5B
↑ 79.76%
Total Liabilities
1.1B
↑ 145.29%
Q2 FY23Q/Q Change
Total Assets
1.3B
↓ 13.46%
Total Liabilities
927.4M
↓ 17.96%
Q3 FY23Q/Q Change
Total Assets
1.1B
↓ 15.76%
Total Liabilities
737.9M
↓ 20.43%
Q4 FY23Q/Q Change
Total Assets
570.7M
↓ 46.15%
Total Liabilities
284.3M
↓ 61.48%
FY18Y/Y Change
Operating Cash Flow
-153.3M
-
Investing Cash Flow
97.5M
-
Financing Cash Flow
74.6M
-
FY19Y/Y Change
Operating Cash Flow
-159.9M
↑ 4.3%
Investing Cash Flow
-181.9M
↓ 286.52%
Financing Cash Flow
334.0M
↑ 347.76%
FY20Y/Y Change
Operating Cash Flow
-2.2M
↓ 98.61%
Investing Cash Flow
137.4M
↓ 175.53%
Financing Cash Flow
858.2M
↑ 156.97%
FY21Y/Y Change
Operating Cash Flow
-282.3M
↑ 12576.74%
Investing Cash Flow
-435.4M
↓ 416.91%
Financing Cash Flow
925.4M
↑ 7.83%
FY22Y/Y Change
Operating Cash Flow
-203.9M
↓ 27.77%
Investing Cash Flow
95.1M
↓ 121.85%
Financing Cash Flow
-5.0M
↓ 100.54%
Q3 FY22Q/Q Change
Operating Cash Flow
101.7M
↓ 359.52%
Investing Cash Flow
-43.4M
↓ 148.56%
Financing Cash Flow
132.0K
↓ 71.18%
Q4 FY22Q/Q Change
Operating Cash Flow
-209.4M
↓ 305.96%
Investing Cash Flow
12.7M
↓ 129.17%
Financing Cash Flow
56.0K
↓ 57.58%
Q1 FY23Q/Q Change
Operating Cash Flow
79.0M
↓ 137.75%
Investing Cash Flow
66.5M
↑ 425.37%
Financing Cash Flow
-2.1M
↓ 3910.71%
Q2 FY23Q/Q Change
Operating Cash Flow
53.2M
↓ 32.72%
Investing Cash Flow
66.5M
↑ 0.0%
Financing Cash Flow
-147.0K
↓ 93.11%

Technicals Summary

Sell

Neutral

Buy

Clover Health Investments Corp. is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Clover Health Investments Corp.
Clover Health Investments Corp.
-19.65%
-31.15%
-17.47%
-91.78%
-91.78%
The Cigna Corp
The Cigna Corp
0.17%
17.05%
37.6%
39.54%
138.12%
Centene Corp.
Centene Corp.
-1.93%
6.05%
11.71%
16.26%
50.23%
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
3.14%
-3.92%
2.49%
25.19%
117.33%
Cvs Health Corporation
Cvs Health Corporation
-11.69%
1.1%
-5.02%
-8.28%
31.7%
Elevance Health, Inc
Elevance Health, Inc
3.42%
17.63%
14.8%
39.93%
117.8%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Clover Health Investments Corp.
Clover Health Investments Corp.
NA
NA
NA
-0.22
-0.66
-0.17
NA
0.59
The Cigna Corp
The Cigna Corp
20.04
20.04
0.89
28.44
0.12
0.04
0.02
158.03
Centene Corp.
Centene Corp.
15.18
15.18
0.68
6.77
0.11
0.04
NA
48.35
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
30.13
30.13
1.24
25.98
0.17
0.07
0.02
100.18
Cvs Health Corporation
Cvs Health Corporation
10.72
10.72
1.0
7.82
0.11
0.04
0.04
59.36
Elevance Health, Inc
Elevance Health, Inc
19.8
19.8
1.14
37.15
0.16
0.06
0.01
173.39
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Clover Health Investments Corp.
Clover Health Investments Corp.
Buy
$312.6M
-91.78%
NA
-10.48%
The Cigna Corp
The Cigna Corp
Buy
$98.9B
138.12%
20.04
2.65%
Centene Corp.
Centene Corp.
Buy
$40.2B
50.23%
15.18
1.91%
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
Buy
$454.7B
117.33%
30.13
4.05%
Cvs Health Corporation
Cvs Health Corporation
Buy
$87.5B
31.7%
10.72
2.34%
Elevance Health, Inc
Elevance Health, Inc
Buy
$122.1B
117.8%
19.8
3.64%

Institutional Holdings

  • Vanguard Group Inc

    4.91%

  • Renaissance Technologies Corp

    2.54%

  • BlackRock Inc

    1.73%

  • PNC Financial Services Group Inc

    1.03%

  • Geode Capital Management, LLC

    0.86%

  • Jupiter Asset Management Limited

    0.77%

Corporate Announcements

  • Clover Health Investments Corp. Earnings

    Clover Health Investments Corp.’s price-to-earnings ratio stands at None

    Read More

Company Information

clover health (nasdaq: clov) is a physician enablement company focused on seniors who have historically lacked access to affordable, high-quality healthcarewe aim to provide great care, in a sustainable way, by having a business model built around improving medical outcomes while lowering avoidable costs. we do this while taking a holistic approach to understanding the health needs and social risk factors of those under our care. this strategy is underpinned by our proprietary software platform, the clover assistant, which is designed to aggregate patient data from across the health ecosystem to support clinical decision-making by presenting physicians and other providers with real-time, personalized recommendations at the point of care.making care more accessible is at the heart of our business, and we believe patients should have the freedom to choose their doctors. we offer affordable medicare advantage plans with extensive benefits, provide primary care physicians with the clover a

Organization
Clover Health Investments Corp.
Employees
552
CEO
Mr. Vivek Garipalli
Industry
Healthcare

Discover More

FAQs